Gateway Aesthetic Institute and Laser Center
Dr. Mark B. Taylor founded the Gateway Aesthetic Institute and Laser Center in Salt Lake City, Utah in 1997, the largest dedicated cosmetic laser center in the world with over 60 lasers and more than a dozen energy devices. He has over 35 years’ experience in cosmetic dermatology and laser treatments.
Dr. Taylor completed a bachelor-of-arts degree at Brigham Young University, medical school at the University of Utah and a dermatology residency at the University of Oregon. He is board-certified in dermatology through the American Board of Dermatology.
Dr. Taylor is a respected leader in the field of cosmetic dermatology laser surgery, pioneering, teaching and publishing new laser techniques to thousands of doctors world-wide. In March 2018 he conducted the Master Circuit Course for the American Society for Dermatologic Surgery. He invented the Taylor Liberator® acne scar subcision instrument used by doctor all over the world to treat rolling acne scars. Dr. Taylor also invented the Poke a Dot Lift® procedure.
He is a fellow of the American Society for Laser Medicine and Surgery and the American Academy of Dermatology, a cosmetic surgery fellowship director for the American Society of Dermatologic Surgery, a member of DASIL and other international professional organizations.
Dr. Taylor is cofounder of SkinCareRx.com on of the world’s largest online vendors of skin care products. He invented 3 cosmeceutical lines including: COSMION®, NuCelle®, and M2.
Dr. Taylor has a passion for treating acne scars, laser resurfacing, birthmarks, laser eyelid surgery, complex cosmetic skin problems and a broad array of other cutaneous laser procedures. Dr. Taylor is one of the most knowledgeable and experience laser physicians in the world. He performs thousands of laser treatments each year as a full-time cosmetic dermatology and laser surgeon.
Dr. Taylor expanded Gateway founding the Gateway Emerging Technologies Medical Clinic in 2015 where functional wellness medicine and FDA-monitored clinical research is conducted.
Friday, April 25, 2025
2:30 PM – 4:00 PM EDT